Vectors Research Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.7M Sell
4,203
-3,078
-42% -$1.25M 0.58% 47
2025
Q1
$3.62M Sell
7,281
-52
-0.7% -$25.9K 1.27% 20
2024
Q4
$3.82M Sell
7,333
-479
-6% -$249K 1.3% 20
2024
Q3
$4.83M Sell
7,812
-124
-2% -$76.6K 1.46% 16
2024
Q2
$4.39M Sell
7,936
-118
-1% -$65.3K 1.35% 21
2024
Q1
$4.68M Sell
8,054
-27,536
-77% -$16M 1.32% 18
2023
Q4
$4.06M Buy
35,590
+27,039
+316% +$3.08M 1.14% 19
2023
Q3
$4.12M Sell
8,551
-62
-0.7% -$29.8K 1.33% 16
2023
Q2
$4.49M Sell
8,613
-207
-2% -$108K 1.28% 15
2023
Q1
$5.08M Sell
8,820
-89
-1% -$51.3K 1.31% 16
2022
Q4
$4.91M Buy
8,909
+402
+5% +$221K 1.27% 17
2022
Q3
$4.32M Sell
8,507
-115
-1% -$58.3K 1.22% 16
2022
Q2
$4.68M Sell
8,622
-170
-2% -$92.4K 1.19% 19
2022
Q1
$5.19M Sell
8,792
-270
-3% -$159K 1.14% 20
2021
Q4
$6.05M Buy
9,062
+53
+0.6% +$35.4K 1.28% 22
2021
Q3
$5.15M Buy
9,009
+207
+2% +$118K 1.21% 22
2021
Q2
$4.44M Buy
8,802
+170
+2% +$85.8K 1.13% 28
2021
Q1
$3.94M Buy
8,632
+104
+1% +$47.5K 1.09% 26
2020
Q4
$3.97M Buy
8,528
+140
+2% +$65.2K 1.22% 22
2020
Q3
$3.72M Sell
8,388
-69
-0.8% -$30.6K 1.36% 20
2020
Q2
$3.06M Buy
8,457
+22
+0.3% +$7.97K 1.21% 22
2020
Q1
$2.39M Buy
8,435
+3,172
+60% +$900K 1.14% 23
2019
Q4
$1.71M Buy
5,263
+1,118
+27% +$363K 0.69% 36
2019
Q3
$1.21M Hold
4,145
0.59% 36
2019
Q2
$1.22M Hold
4,145
0.66% 37
2019
Q1
$1.14M Buy
4,145
+4,000
+2,759% +$1.1M 0.64% 38
2018
Q4
$32K Sell
145
-3,975
-96% -$877K 0.02% 246
2018
Q3
$847K Buy
+4,120
New +$847K 0.52% 44